7Z8-12262-69218
1 vaccination
1 coded response
16 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 483 / MI
- Registered
- 2021-03-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-22
Registered in v-safe
-
2021-03-22
Dose 1 — Janssen/Johnson & Johnson
- 2021-03-22
-
2021-03-23
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fever · HeadacheAdult check-in
- 2021-03-24
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-04-05
- 2021-04-12
- 2021-04-19
- 2021-04-26
- 2021-05-03
- 2021-06-21
-
2021-09-20
Survey response — 6 months, dose 1MedDRA: Delivery, Dermatitis allergic, Hypersensitivity — Feeling: GoodFree text: Childbirth Allergic reaction rash unknown originMedDRA releases: 2024-11 · check-in free text available
- 2022-03-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-22 | Janssen/Johnson & Johnson |
Free text
Release 9 — 6 months, dose 1
Symptoms: Childbirth Allergic reaction rash unknown origin
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Delivery | · | · | ✓ |
| SD | Dermatitis allergic | · | · | ✓ |
| SD | Hypersensitivity | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release